Discovery of novel phenoxybenzamide analogues as Raf/HDAC dual inhibitors

Discovery of novel phenoxybenzamide analogues as Raf/HDAC dual inhibitors Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors Design, synthesis and evaluate of novel dual FGFR1 and HDAC inhibitors bearing an indazole scaffold Design, synthesis and activity evaluation of indole-based double – Branched HDAC1 inhibitors Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives